PlainRecalls
LowClass IIIOngoing

FDA Drug recall · Reported April 22, 2026

Magnesium Chloride, 6-Hydrate, Crystal, 500G per bottle, Bulk active pharmaceutical ingredient (API), Avantor Performance Materials, LLC, 100 Matsonford Road, Suite 200, Radnor, PA 19087, NDC 10106-2448-1

Subpotent drug

Recall #
D-0488-2026
Affected scope
36 bottles
Initiated
March 31, 2026
Verify with FDA Drug →
View my saved recalls

The recall

Avantor Performance Materials LLC issued this low-severity FDA Drug recall — Subpotent drug.

Low
severity level
Class III
classification
April 22, 2026
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0488-2026 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0488-2026) was formally reported on April 22, 2026, with the manufacturer initiating the action on March 31, 2026. It is classified under Low severity (Class III), with a current status of Ongoing. Avantor Performance Materials LLC is listed as the recalling firm, operating out of Paris, KY. Federal records list the affected scope as 36 bottles.

The documented reason for this recall is: Subpotent drug Distribution data in the federal record shows the product reached: Nationwide in the USA, Belgium and France. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug — clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category — 14,048 drugs & medications recalls on record

-50005001,0001,5002,000 20052009201220152018202120242026 216

Where this recall sits in the database

Severity2366872097High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified low severity.

Severity

Low

Affected scope

36 bottles

Related Recalls

6

5 from same agency

Product description

Magnesium Chloride, 6-Hydrate, Crystal, 500G per bottle, Bulk active pharmaceutical ingredient (API), Avantor Performance Materials, LLC, 100 Matsonford Road, Suite 200, Radnor, PA 19087, NDC 10106-2448-1

Reason for recall

Subpotent drug

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Low (Class III)
Status Ongoing
Recall number D-0488-2026
Date reported April 22, 2026
Date initiated March 31, 2026
Recalling firm Avantor Performance Materials LLC
Firm location Paris, KY
Affected scope 36 bottles
Distribution Nationwide in the USA, Belgium and France

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0488-2026) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting — recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Magnesium Chloride, 6-Hydrate, Crystal, 500G per bottle, Bulk active pharmaceutical ingredient (API), Avantor Performance Materials, LLC, 100 Matsonford Road, Suite 200, Radnor, PA 19087, NDC 10106-2448-1. Recalled by Avantor Performance Materials LLC. Units affected: 36 bottles.
Why was this product recalled?
Subpotent drug
Which agency issued this recall?
This recall was issued by the FDA Drug on April 22, 2026. Severity: Low. Recall number: D-0488-2026.
Where was the recalled product distributed?
Distribution: Nationwide in the USA, Belgium and France.
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0488-2026) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Nicotine Transdermal System Patch, 14 mg, 14 patches per bo… →

Data Sources

Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Drug, reported April 22, 2026.

  • Source: FDA — Food and Drug Administration, openFDA Enforcement API (food, drug, and medical device recalls)
  • Source: CPSC — Consumer Product Safety Commission Recalls API (consumer product recalls and hazards)
  • Source: NHTSA — National Highway Traffic Safety Administration Recalls API (vehicle safety recalls)

Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records — no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.